|
Real-time Estimate
Tradegate
07:55:40 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 124.80 EUR | -8.58% |
|
-0.93% | -18.00% |
| 06:01am | Investors nervous about AI spending slowdown after industry warnings | RE |
| 09-14 | Oracle Health Announces U.S. Availability Of Oracle Health Clinical AI Agent For Nurses | CI |
Company Valuation: Oracle Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 191,894 | 286,017 | 322,098 | 464,185 | 649,354 | 437,807 | - | - |
| Change | - | 49.05% | 12.62% | 44.11% | 39.89% | -32.58% | - | - |
| Enterprise Value (EV) 1 | 245,851 | 366,311 | 398,306 | 545,550 | 747,001 | 554,697 | 595,453 | 586,126 |
| Change | - | 49% | 8.73% | 36.97% | 36.93% | -25.74% | 7.35% | -1.57% |
| P/E | 29.8x | 34.5x | 31.6x | 38.1x | 38.7x | 22.2x | 15.9x | 10.8x |
| PBR | -34.7x | 268x | 34.9x | 22x | 15.3x | 4.94x | 3.45x | 2.73x |
| PEG | - | 1.3x | 1.5x | 2.2x | 1.1x | 1.9x | 0.4x | 0.2x |
| Capitalization / Revenue | 4.52x | 5.73x | 6.08x | 8.09x | 9.64x | 4.84x | 3.33x | 2.39x |
| EV / Revenue | 5.79x | 7.33x | 7.52x | 9.5x | 11.1x | 6.13x | 4.53x | 3.2x |
| EV / EBITDA | 11.4x | 15.6x | 15.2x | 18.9x | 20.4x | 10.5x | 8.04x | 5.45x |
| EV / EBIT | 12.5x | 17.5x | 17.3x | 21.8x | 25.8x | 15.3x | 12.1x | 8.54x |
| EV / FCF | 48.9x | 43.2x | 33.7x | -1,385x | -31.5x | -14.4x | -17.6x | 86x |
| FCF Yield | 2.05% | 2.31% | 2.96% | -0.07% | -3.17% | -6.92% | -5.67% | 1.16% |
| Dividend per Share 2 | 1.28 | 1.36 | 1.6 | 2 | 2 | 1.994 | 2.081 | 2.201 |
| Rate of return | 1.78% | 1.28% | 1.37% | 1.21% | 0.89% | 1.38% | 1.44% | 1.52% |
| EPS 2 | 2.41 | 3.07 | 3.71 | 4.34 | 5.83 | 6.518 | 9.113 | 13.39 |
| Distribution rate | 53.1% | 44.3% | 43.1% | 46.1% | 34.3% | 30.6% | 22.8% | 16.4% |
| Net sales 1 | 42,440 | 49,954 | 52,961 | 57,399 | 67,357 | 90,429 | 131,344 | 182,957 |
| EBITDA 1 | 21,565 | 23,428 | 26,184 | 28,900 | 36,549 | 52,819 | 74,030 | 107,543 |
| EBIT 1 | 19,593 | 20,902 | 23,055 | 25,033 | 28,926 | 36,282 | 49,085 | 68,611 |
| Net income 1 | 6,717 | 8,503 | 10,467 | 12,443 | 16,984 | 20,363 | 28,470 | 43,730 |
| Net Debt 1 | 53,957 | 80,294 | 76,208 | 81,365 | 97,647 | 116,890 | 157,647 | 148,319 |
| Reference price 2 | 71.92 | 105.94 | 117.19 | 165.53 | 225.78 | 144.79 | 144.79 | 144.79 |
| Nbr of stocks (in thousands) | 2,668,157 | 2,699,802 | 2,748,514 | 2,804,234 | 2,876,046 | 3,023,736 | - | - |
| Announcement Date | 13/06/22 | 12/06/23 | 11/06/24 | 11/06/25 | 10/06/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.21x | 6.13x | 10.5x | 1.38% | 438B | |
| 26.39x | 5.29x | 16.69x | 1.44% | 248B | |
| 92.15x | 8.97x | 24.01x | -.--% | 147B | |
| -5.24x | 108.09x | 1508.9x | -.--% | 52.62B | |
| 36.45x | 3.42x | 12.6x | 0.19% | 45.07B | |
| 26.65x | 10.6x | 17.31x | -.--% | 21.63B | |
| 34.81x | 2.3x | 20.96x | -.--% | 19.24B | |
| -211.68x | 3.75x | 12.55x | - | 13.7B | |
| 38.97x | 3.4x | 9.27x | -.--% | 13.04B | |
| Average | 6.74x | 16.88x | 181.42x | 0.38% | 110.93B | |
| Weighted average by Cap. | 30.10x | 11.55x | 93.45x | 0.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORCL Stock
- ORCL Stock
- Valuation Oracle Corporation
Select your edition
All financial news and data tailored to specific country editions
